Two-day summit seeks to accelerate the integration of rigorously tested longevity interventions into clinical practice.
The first Asian Pacific Longevity Medicine International Summit will convene October 4–5, 2025, at the SkyCity Marriott Hotel in Hong Kong, positioning the Asia-Pacific region at the center of a growing global movement to transform longevity science into practical healthcare. Organized by the Asia-Pacific Longevity Society, the gathering is designed to set clear standards for a field that has often been overshadowed by lifestyle trends and commercial claims, bringing focus back to evidence, clinical training, and patient benefit.
The two-day summit is expected to draw participation from more than 30 countries, representing regions that together account for over half of the world’s population. Many of these, including Japan, Singapore, and Hong Kong, are considered “super-aging” societies where demographic pressures have created urgency for scalable approaches to extending healthspan. Organizers are framing the event not as a showcase of futuristic promises, but as a platform to accelerate the integration of rigorously tested longevity interventions into clinical and community settings.
Programming will span several tracks. Intensive training courses will target healthcare providers, aiming to equip them with the skills and knowledge to deliver safe and effective longevity care. The summit will also highlight successful models of longevity clinics and healthy aging centers, presenting case studies from both public and private healthcare systems. A “Living Lab” will provide space for testing non-medical innovations, including technologies and lifestyle solutions that support wellbeing outside traditional clinical frameworks.
One of the central features of the event will be the announcement of the Top 10 Longevity Breakthrough Awards. Selected by an advisory committee, these awards are intended to spotlight interventions ready for near-term clinical or consumer application, ranging from therapeutics to diagnostic tools and home-based health solutions. This recognition is positioned as a way to distinguish credible science-driven advances from unverified commercial offerings that have historically clouded the field.
Speakers will include physician-scientists, biotech founders, and international experts working to bridge the gap between geroscience research and medical practice. The emphasis will be on how longevity medicine can be integrated into mainstream hospital systems and specialized clinics alike, ensuring that developments in the lab translate into accessible, ethical patient care.
The summit’s mission focuses on striking a balance between clinical rigor and practical application. By convening a diverse set of stakeholders, from researchers and physicians to investors and entrepreneurs, the event is intended to help establish longevity medicine as a recognized specialty, rather than a passing trend.
The Hong Kong gathering is the first in what is expected to become a recurring series of international meetings. For clinicians, the summit offers direct access to emerging standards and training. For investors, it provides an entry point into a field that is moving from research to real-world application. And for policymakers and healthcare systems in rapidly aging societies, it represents an opportunity to assess how longevity medicine can contribute to extending not just lifespan, but quality of life.
